ZFIN ID: ZDB-FISH-150901-6628
Fish name: nz50Tg
Genotype: nz50Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by nz50Tg
Human Disease Conditions Citations
bacterial infectious disease bacterial treatment by injection: Pseudomonas aeruginosa PAK McCarthy et al., 2017
GENE EXPRESSION
Gene expression in nz50Tg
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab1-pycard control Fig. 1 from Kuri et al., 2017
Ab1-wasb standard conditions Fig. S1 with image from Jones et al., 2013
PHENOTYPE
Phenotype in nz50Tg
Phenotype Conditions Figures
blood island neutrophil normal amount, normal bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium Fig. 3 with image from Oehlers et al., 2011
hindbrain neutrophil increased amount, abnormal bacterial treatment by injection: Pseudomonas aeruginosa PAK Fig. 5 from McCarthy et al., 2017
inflammatory response increased occurrence, abnormal resection: caudal fin Fig. 2 with image from Antonio et al., 2015
inflammatory response to wounding increased process quality, abnormal laceration: ventral fin fold Fig. 3 with imageFig. 4 with image from Wittmann et al., 2015
inflammatory response to wounding increased process quality, ameliorated laceration: ventral fin fold, chemical treatment: 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one Fig. 3 with image from Wittmann et al., 2015
inflammatory response to wounding increased process quality, ameliorated laceration: ventral fin fold, chemical treatment: EC 1.14.13.39 (nitric oxide synthase) inhibitor Fig. 3 with image from Wittmann et al., 2015
inflammatory response to wounding increased process quality, ameliorated laceration: ventral fin fold, chemical treatment: N(gamma)-nitro-L-arginine methyl ester hydrochloride Fig. 3 with image from Wittmann et al., 2015
leukocyte nitric-oxide synthase activity increased process quality, abnormal bacterial treatment Fig. 5 with image from Elks et al., 2013
liver neutrophil increased amount, abnormal chemical treatment by diet: fructose Fig. 1 from Yan et al., 2017
liver neutrophil increased amount, abnormal chemical treatment by diet: cholesterol Fig. 1 from Yan et al., 2017
male organism neutrophil htr2b expression increased amount, abnormal standard conditions Fig. 3 with image from Yang et al., 2017
neutrophil decreased amount, abnormal bacterial treatment by injection: Shigella flexneri Fig. 3 with image from Mazon-Moya et al., 2017
neutrophil increased amount, abnormal resection: caudal fin Fig. 2 with image from Antonio et al., 2015
neutrophil normal amount, normal chemical treatment: pharmaceutical Fig. 3 with image from Herbst et al., 2015
neutrophil cell population proliferation increased occurrence, abnormal chemical treatment by environment: 1,4-benzoquinone Fig. 3 with image from Zhang et al., 2019
neutrophil chemotaxis decreased process quality, abnormal amputation: caudal fin, chemical treatment: U-73122 Fig. 1 from de Oliveira et al., 2014
neutrophil chemotaxis decreased process quality, abnormal amputation: caudal fin, chemical treatment: dibenziodolium chloride Fig. 2 from de Oliveira et al., 2014
neutrophil chemotaxis decreased process quality, abnormal amputation: caudal fin, chemical treatment: Suramin sodium Fig. 1 from de Oliveira et al., 2014
neutrophil chemotaxis decreased process quality, abnormal amputation: caudal fin, chemical treatment: tetrasodium 5'-phosphonatopyridoxal-6-azobenzene-2,4-disulfonate Fig. 1 from de Oliveira et al., 2014
neutrophil chemotaxis decreased process quality, abnormal amputation: caudal fin, chemical treatment: thapsigargin Fig. 1 from de Oliveira et al., 2014
neutrophil chemotaxis decreased process quality, abnormal amputation: caudal fin, chemical treatment: adenosine phosphate Fig. 1 from de Oliveira et al., 2014
response to fungus disrupted, abnormal chemical treatment: tacrolimus (anhydrous), fungal treatment by injection: Aspergillus fumigatus Fig. 3 with image from Herbst et al., 2015
response to fungus process quality, normal fungal treatment by injection: Aspergillus fumigatus Fig. 3 with image from Herbst et al., 2015
swim bladder neutrophil increased amount, abnormal bacterial treatment by injection: Waddlia chondrophila WSU 86-1044 Fig. 5 with image from Fehr et al., 2016
tumor necrosis factor-mediated signaling pathway disrupted, abnormal chemical treatment: tacrolimus (anhydrous), fungal treatment by injection: Aspergillus fumigatus Fig. 3 with image from Herbst et al., 2015
ventral wall of dorsal aorta neutrophil increased amount, abnormal bacterial treatment: Salmonella enterica subsp. enterica serovar Typhimurium Fig. 5 with image from Hall et al., 2012
whole organism dead, abnormal fungal treatment by injection: Aspergillus fumigatus Fig. 3 with image from Herbst et al., 2015
whole organism dead, abnormal chemical treatment: tacrolimus (anhydrous), fungal treatment by injection: Aspergillus fumigatus Fig. 3 with image from Herbst et al., 2015
whole organism viability, abnormal bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium Fig. 2 with image from Oehlers et al., 2011

CITATIONS  (68)